Ipca Labs subsidiary acquires 80% stake in Bayshore Pharmaceuticals for USD 10.28 mn

The acquisition will enable the company to commercialise its registered generics drug products in the US market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2O08NUl
via IFTTT